[시장보고서]세계의 뇌자도 시장(2023-2030년)

세계의 뇌자도 시장(2023-2030년)

Global Magnetoencephalography Market - 2023-2030

상품코드 : 1319142

리서치사 : DataM Intelligence

발행일 : 2023년 07월

페이지 정보 : 영문 195 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,350

￦ 6,016,000

PDF & Excel (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,850

￦ 6,708,000

PDF & Excel (Multiple User License)

PDF 보고서를 동일 사업장에서 7명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,850

￦ 10,858,000

PDF & Excel (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

시장 개요

세계의 뇌자도 시장은 2022년에 2억 7,380만 달러에 달하며, 2030년에는 4억 880만 달러까지 성장할 것으로 예측되고 있습니다. 세계의 뇌자도 시장은 예측 기간 중(2023-2030년) CAGR 5.2%를 보일 것으로 예측됩니다.

간질 환자의 검사 및 수술 계획은 뇌자도 검사로부터 큰 혜택을 받을 수 있습니다. 간질 유발 영역은 간질 발작을 유발하는 뇌의 비정상적인 활동의 정확한 영역을 말합니다. 이 정보는 중요한 기능 영역을 보호하면서 손상된 뇌 조직을 절단하거나 제거하기 위한 최적의 수술적 접근 방식을 선택하는 데 필수적입니다.

시장 역학

뇌 연구에 대한 관심이 높아짐에 따라 예측 기간 중 세계 뇌자도 시장의 성장을 가속하고 있습니다.

뇌 건강은 끊임없이 변화하는 개념이며, 건강 산업뿐만 아니라 일반 대중의 관심을 받고 있는데, 여기에는 그럴만한 이유가 있습니다. 노년기에 임상적 치매로 이어지는 신경 퇴행성 변화를 막는 가장 큰 전략은 위험 요인을 조기에 발견하고 관리하는 것임에도 불구하고, 뇌 건강 위험에 대한 연구는 여전히 중년과 노년층을 대상으로 하고 있습니다.

뇌 헬스케어를 위한 지역 기반 서비스는 소통과 조기 위험 프로파일링을 위한 새로운 기회를 제공할 것입니다. 그 결과, 치매의 역학과 치료 효과에 대한 우리의 지식을 발전시킬 수 있는 방대한 양의 데이터가 생성될 것으로 예상됩니다.

임상 진단에서의 용도 증가는 세계 뇌자도 시장의 성장 기회를 제공합니다.

MEG는 일부 환자에서 뇌진탕의 임상 진단 기술로서의 가능성을 보여주고 있습니다. 밀리초의 시간 분해능을 가진 MEG는 뇌의 기능적 해부학적 구조를 매핑하는 비침습적 방법입니다. 이는 신경세포의 전기적 활동에 의해 발생하는 자기장을 감지하여 이루어집니다. 축삭 다발에서 발생하는 시냅스 후 전위는 MEG가 포착할 수 있는 자기장을 동반한 세포내 전류를 생성합니다.

MEG는 두개골 표면 전체에 설치된 고정밀 첨단 센서를 사용하여 자기장을 포착하여 X선, 외부 자기장, 방사성동위원소(핵의학에서 사용)를 사용하지 않고도 이미지를 생성할 수 있습니다. MEG는 정상적인 뇌 활동과 병적인 뇌 활동을 장소와 시간에 따라 구분하는 능력에서 기존 기술을 발전시키고 있습니다. 자기장을 감지하여 각 자기장을 생성하는 세포 집합체를 밀리초 단위의 시간 분해능으로 식별할 수 있습니다.

COVID-19의 영향 분석

COVID-19 전염병은 뇌자도 시장에 큰 영향을 미쳤습니다. 팬데믹은 공급망의 혼란, 물류의 어려움, 재정적 불확실성을 야기했습니다. 이러한 요소로 인해 MEG 시스템 설치 및 획득이 지연되었을 수 있습니다. 예산이 부족한 병원, 연구시설, 진료소 또는 전염병으로 인한 긴급한 의료 수요에 대응하는 병원은 새로운 MEG 장비 구매를 늦추거나 규모를 줄였을 수 있습니다.

러시아·우크라이나 분쟁 분석

러시아와 우크라이나의 전쟁이 뇌자도 시장에 미치는 영향은 복잡하고 다면적입니다. 분쟁으로 인한 혼란으로 인해 질병 감시 및 검진 구상을 성공적으로 수행하기가 어렵습니다. 질병 감시와 대응을 방해하여 전염병의 식별과 봉쇄를 지연시킬 수 있습니다.

영문목차

Market Overview

The global Magnetoencephalography Market reached US$ 273.8 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 408.8 million by 2030. The global Magnetoencephalography market is expected to exhibit a CAGR of 5.2% during the forecast period (2023-2030).

The examination and surgical planning of individuals with epilepsy benefit greatly from Magnetoencephalography. The epileptogenic zone the precise area of aberrant brain activity that causes seizures can be located with the aid of this technique. This information is essential for selecting the best surgical approach to disconnect or remove damaged brain tissue while protecting critical functional regions.

Market Dynamics

Increased focus on brain research is boosting the global magnetoencephalography market growth during the forecast period.

Brain health is a concept that is always changing, gaining attention from the health industry as well as from the general public, and it does so for good reasons. Despite the greatest strategy to stop neurodegenerative changes that lead to clinical dementia later in life is early detection and control of risk factors, research on hazards to brain health still focuses on middle-aged and older persons.

New chances for communicating and early risk profiling are offered by community-based services for managing brain health. Large volumes of data will be produced as a result, advancing our knowledge of the epidemiology of dementia and the effectiveness of therapies.

Increasing applications in clinical diagnostics provide global magnetoencephalography market growth opportunities.

MEG has demonstrated potential as a clinical diagnostic technique for concussion in some patients. With a millisecond time resolution, MEG is a non-invasive method of mapping the functional anatomy of the brain. It does this by detecting magnetic fields produced by neuronal electrical activity. Postsynaptic potentials generated by bundles of axons result in intracellular currents with a magnetic field that can be picked up by MEG.

Magnetic fields are captured by MEG using highly accurate and sophisticated sensors throughout the surface of the skull. Without the need for X-rays, external magnetic fields, or radioactive isotopes (used in nuclear medicine), images can be produced. In its capacity to distinguish between normal and pathological brain activity in location and time, MEG advances existing technology. The cell assemblies that create each field may be located with an unmatched millisecond temporal resolution by detecting the magnetic fields.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the magnetoencephalography market. The pandemic has caused supply chain disruptions, logistical difficulties, and financial uncertainty. These elements might have contributed to a delay in the installation and acquisition of MEG systems. Hospitals, research facilities, and clinics with tight budgets or those attending to the pressing healthcare need brought on by the epidemic may have delayed or scaled back purchases of new MEG equipment.

Russia-Ukraine Conflict Analysis

The impact of the Russia-Ukraine war on the magnetoencephalography market is complex and multifaceted. Because of the disruption caused by the conflict, illness surveillance, and screening initiatives are difficult to successfully implement. Disease surveillance and response could be hampered, which could delay the identification and containment of epidemics.

Segment Analysis

The global magnetoencephalography market is segmented based on application, end-user, and region.

The clinical segment is expected to hold a dominant position in the market over the forecast period.

The clinical segment accounted for the highest market stake accounting for approximately 57.8% of the Magnetoencephalography market in 2022. Around the world, Alzheimer's disease (AD) accounts for 60% of all occurrences of dementia, making it the most common cause of the illness. With age, there is a higher chance of acquiring AD. In terms of source localization, MEG clearly gives a benefit.

The potential of MEG to predict conversion across the several stages of the disease (preclinical-prodromal-dementia) is a key aspect to take into account when using MEG as a biomarker for AD. There aren't many longitudinal studies and those that do all addressed the transition from MCI to dementia.

Geographical Analysis

Advancements in magnetoencephalography dominate the European region.

Europe is expected to dominate the magnetoencephalography market, accounting for around 27.8% of this market. No external fields or injections are used in the MEG process; instead, it detects magnetic fields that the brain naturally produces. The most sophisticated clinical use of MEG is for epilepsy diagnosis.

Epilepsy affects six million individuals in Europe alone, and there are roughly 300,000 new cases every year. There are more applications for MEG, such as the diagnosis of mild traumatic brain injuries (TBI), which accounts for more than half of the 2.5 million new TBI cases in Europe each year.

Competitive Landscape

The major global players in the market include: Compumedics Limited, MEGIN, Ricoh USA, Inc., CTF MEG INTERNATIONAL SERVICES LP, FieldLine Inc., Cerca Magnetics Limited, and Croton Healthcare among others.

Why Purchase the Report?

To visualize the global magnetoencephalography market segmentation based on the application, end-user, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of magnetoencephalography market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global magnetoencephalography market report would provide approximately 44 tables, 43 figures, and 195 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Application
3.2. Snippet by End-user
3.3. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. The increasing incidence of dementia
- 4.1.2. Restraints
  - 4.1.2.1. Challenges associated with magnetoencephalography
- 4.1.3. Opportunity
  - 4.1.3.1. The increasing applications in clinical diagnostics
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers' Strategic Initiatives
6.6. Conclusion

7. Russia-Ukraine War Analysis

8. Artificial Intelligence Analysis

9. By Application

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
9.2. Clinical*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 9.2.3. Dementia
- 9.2.4. Autism
- 9.2.5. Schizophrenia
- 9.2.6. Multiple Sclerosis
- 9.2.7. Stroke
- 9.2.8. Epilepsy
- 9.2.9. Others
9.3. Research

10. By End-user

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 10.1.2. Market Attractiveness Index, By End-user
10.2. Hospitals*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Diagnostic Imaging centers
10.4. Academic and Research Institutes

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.5.1. U.S.
  - 11.2.5.2. Canada
  - 11.2.5.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.5.1. Germany
  - 11.3.5.2. U.K.
  - 11.3.5.3. France
  - 11.3.5.4. Italy
  - 11.3.5.5. Spain
  - 11.3.5.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.5.1. Brazil
  - 11.4.5.2. Argentina
  - 11.4.5.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.5.1. China
  - 11.5.5.2. India
  - 11.5.5.3. Japan
  - 11.5.5.4. Australia
  - 11.5.5.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Product Benchmarking
12.3. Company Share Analysis
12.4. Key Developments and Strategies

13. Company Profiles

13.1. Compumedics Limited*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. MEGIN
13.3. Ricoh USA, Inc.
13.4. CTF MEG INTERNATIONAL SERVICES LP
13.5. FieldLine Inc.
13.6. Cerca Magnetics Limited
13.7. Croton healthcare

LIST NOT EXHAUSTIVE

14. Appendix

14.1. About Us and Services
14.2. Contact Us